Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 1757(5-6): 525-34, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16678116

RESUMO

Mitochondria can be a source of reactive oxygen species (ROS) and a target of oxidative damage during oxidative stress. In this connection, the effect of photodynamic treatment (PDT) with Mitotracker Red (MR) as a mitochondria-targeted photosensitizer has been studied in HeLa cells. It is shown that MR produces both singlet oxygen and superoxide anion upon photoactivation and causes photoinactivation of gramicidin channels in a model system (planar lipid bilayer). Mitochondria-targeted antioxidant (MitoQ) inhibits this effect. In living cells, MR-mediated PDT initiates a delayed ("dark") accumulation of ROS, which is accelerated by inhibitors of the respiratory chain (piericidin, rotenone and myxothiazol) and inhibited by MitoQ and diphenyleneiodonium (an inhibitor of flavin enzymes), indicating that flavin of Complex I is involved in the ROS production. PDT causes necrosis that is prevented by MitoQ. Treatment of the cell with hydrogen peroxide causes accumulation of ROS, and the effects of inhibitors and MitoQ are similar to that described for the PDT model. Apoptosis caused by H2O2 is augmented by the inhibitors of respiration and suppressed by MitoQ. It is concluded that the initial segments of the respiratory chain can be an important source of ROS, which are targeted to mitochondria, determining the fate of the cell subjected to oxidative stress.


Assuntos
Mitocôndrias/fisiologia , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Antioxidantes/farmacologia , Morte Celular , Respiração Celular , Escuridão , Gramicidina/metabolismo , Células HeLa , Humanos , Peróxido de Hidrogênio/farmacologia , Luz , Bicamadas Lipídicas/química , Metacrilatos/farmacologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/efeitos da radiação , Oniocompostos/farmacologia , Compostos Organofosforados/farmacologia , Fotoquimioterapia , Fármacos Fotossensibilizantes/farmacologia , Rotenona/farmacologia , Oxigênio Singlete/metabolismo , Superóxidos/metabolismo , Tiazóis/farmacologia , Ubiquinona/análogos & derivados , Ubiquinona/farmacologia
2.
Biochim Biophys Acta ; 1658(1-2): 141-7, 2004 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-15282185

RESUMO

In HeLa cells, complete inhibition of oxidative phosphorylation by oligomycin, myxothiazol or FCCP combined with partial inhibition of glycolysis by DOG resulted in a steady threefold decrease in the intracellular ATP level. The ATP level recovers when the DOG-containing medium was replaced by that with high glucose. In 48 h after a transient (3 h) [ATP] lowering followed by recovery of the ATP level, the majority of the cells commits suicide by means of apoptosis. The cell death does not occur if DOG or an oxidative phosphorylation inhibitor was added separately, treatments resulting in 10-35% lowering of [ATP]. Apoptosis is accompanied by Bax translocation to mitochondria, cytochrome c release into cytosol, caspase activation, reactive oxygen species (ROS) generation, and reorganization and decomposition of chromatin. Apoptosis appears to be sensitive to oncoprotein Bcl-2 and a pancaspase inhibitor zVADfmk. In the latter case, necrosis is shown to develop instead of apoptosis. The cell suicide is resistant to cyclosporine A, a phospholipase inhibitor trifluoroperazine, the JNK and p38 kinase inhibitors, oligomycin, N-acetyl cysteine and mitoQ, differing in these respects from the tumor necrosis factor (TNF)- and H(2)O(2)-induced apoptoses. It is suggested that the ATP concentration in the cell is monitored by intracellular "ATP-meter(s)" generating a cell suicide signal when ATP decreases, even temporarily, below some critical level (around 1 mM).


Assuntos
Trifosfato de Adenosina/metabolismo , Apoptose/fisiologia , Espaço Intracelular/metabolismo , Trifosfato de Adenosina/análise , Trifosfato de Adenosina/deficiência , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Caspases/metabolismo , Citocromos c/metabolismo , Citosol/metabolismo , Desoxiglucose/farmacologia , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Metacrilatos , Mitocôndrias/metabolismo , Oligomicinas/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Tiazóis/farmacologia , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA